NASDAQ OMX

Compuware and Wipro Jointly Launch a Mainframe Center of Excellence

Dela

Best Practices Empower Large Global Enterprises to Better Leverage High-Value Systems of Record in Fast-Moving Digital Markets

  • Modernized mainframe systems of record are critical digital investments for large global enterprises-delivering unmatched reliability, scalability, performance and security.
  • Unfortunately, outdated processes and tools often prevent enterprises from adapting their existing mainframe applications to meet changing business needs with the same agility achieved on other platforms.
  • Compuware and Wipro are addressing this challenge through a joint Mainframe Center of Excellence (CoE) that enables Wipro to formulate best practices for achieving mainframe agility and cross-platform DevOps integration, as well as gain mastery of Compuware's software.
  • By leveraging Compuware's software and Wipro's best practices, enterprises can gain the combined competitive advantages of scale and speed, while also successfully navigating a difficult generational shift in mainframe stewardship.

DETROIT, July 25, 2017 (GLOBE NEWSWIRE) --  Compuware Corporation today announced the launch of a Mainframe Center of Excellence (CoE) in partnership with Wipro Limited (NYSE:WIT) (BSE:507685) (NSE:WIPRO), a leading global information technology, consulting and business process services company. The Mainframe CoE will be dedicated to helping large global enterprises better leverage their systems of record for competitive advantage in fast-moving digital markets.

Enterprise IT leaders grapple with mainframe environments that are mired in traditional "waterfall" development, inadequately integrated into cross-platform DevOps workflows and foreign to the Millennials who will ultimately be responsible for the platform's future. The innovative Mainframe CoE, which Wipro will operate, strengthens the company's ability to transform customers' mainframe environments and drive competitive advantage through the adoption of cross-platform Agile and DevOps best practices.  

Compuware is enabling Wipro technical consultants, via hands-on access to Compuware's proven solutions and ongoing training, to establish industry-leading expertise in: agile development on the mainframe, integration of mainframe dev/test/release processes into multi-platform enterprise DevOps toolchains, and modernized workspaces that empower Millennials to effectively work with mainframe resources in the same manner as they work with other platforms. Wipro's extensive experience along with this deep expertise of Compuware's mainframe software, will provide an empirical foundation for the CoE's best-practice recommendations.

The collaboration also serves as another resource for continual improvement towards an Agile mainframe. With direct experience using Compuware's products to discover better ways to leverage mainframe applications and data, Wipro can assist their enterprise clientele in achieving greater innovation throughput and quality that's essential to competing in the digital age.

Benefits to enterprise customers include:

  • Dramatically improved digital agility
  • Substantial reductions in mainframe TCO
  • Greater business value and competitive differentiation from investments in mainframe applications, data and processing power
  • Successful transition of mainframe stewardship from Baby Boomers to less specifically mainframe-experienced Millennials

For large global enterprises, mainframes are irreplaceable and invaluable systems of record. They are repositories of business logic, customer data and other intellectual property that have been carefully and continuously honed over many decades. Unfortunately, a combination of outmoded processes, tools and culture renders many enterprises incapable of quickly adapting their systems of record as necessary to fulfill the relentlessly changing needs of the business.

This lack of speed is in marked contrast to the Agile, DevOps and Continuous Delivery disciplines that they have been able to apply to applications running on other platforms such as private and public clouds. This can greatly hamper competitiveness of large enterprises vis-a-vis smaller, nimbler companies. The new Mainframe CoE addresses this critical challenge by capturing and sharing best practices for optimizing mainframe agility and mainstreaming of the mainframe into broader multi-platform enterprise architectures. 

"Compuware's focus on mainframe Agility and DevOps enablement aligns with our own approach to mainframe applications. We believe this CoE will accelerate the digital journeys for our global clients especially those of large enterprises," said Jatin Mehta, Head, Mainframe Application Services, Wipro Limited. "By leveraging Compuware's technology in the context of a broader enterprise strategy for digital excellence, Wipro can substantially enhance our enterprise customers' ability to innovate in a marketplace where rapid parity is a must," he added.

"Partnering with Wipro on a mainframe-centric CoE affords us a great opportunity to demonstrate exactly how our technology supports the kind of aggressive evolution enterprises absolutely must bring to bear on their mainframes. This will be key to their ability to survive and thrive in an innovation-based economy," said Compuware CEO Chris O'Malley. "We look forward to a long and fruitful collaboration with Wipro-which clearly has tremendous visibility into both the nature of the enterprise's current mainframe challenges and the path to helping these users overcome those challenges in a timely manner."

Compuware Corporation
Compuware empowers the world's largest companies to excel in the digital economy by fully leveraging their high-value mainframe investments. We do this by delivering highly innovative solutions that uniquely enable IT professionals with mainstream skills to manage mainframe applications, data, and platform operations. Learn more at compuware.com.

Follow us on:

Press Contact
Kristina LeBlanc, The Medialink Group, kristinawleblanc@gmail.com, (508) 930-5636
Mary McCarthy, Public Relations Manager, Compuware, mary.mccarthy@compuware.com, (313) 227-7088

For Sales and Marketing Information
Compuware Corporation, One Campus Martius, Detroit MI 48226, 800-521-9353, compuware.com.

Copyright © 2017 Compuware Corporation. Compuware, the Compuware logo, and Topaz are registered or pending registration with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Compuware Corporation via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.

Senaste pressmeddelandena från NASDAQ OMX

XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer18.10.2017 16:53Pressmeddelande

AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposome injection) and 5-fluorouracil/folinic acid in combination with MABp1 in a cohort of patients with advanced pancreatic adenocarcinoma and cachexia. The patient has begun treatment at Cedars-Sinai Medical Center under the care of Dr. Andrew Hendifar, the Study's Principle Investigator, Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai. A total of 16 patients are expected to be enrolled in the study. Dr. Hendifar commented, "We are excited to enroll our first patient in this novel combinatorial therapy for the treatment of advanced pancreatic cancer and cachexia. This is the first attempt to add an anti-inflammatory therapy to standard chemotherapy in an effort to improve the performanc

Nasdaq and SGX Establish Collaborative Listings Agreement18.10.2017 15:42Pressmeddelande

NEW YORK and SINGAPORE, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (Nasdaq:NDAQ) and Singapore Exchange (SGX) today announced the signing of a collaborative agreement in a move to leverage their strengths as two of the leading listings venues in the U.S. and Asia respectively. The new agreement seeks to enhance the channels available for companies to access capital market funding and enhance their corporate profile in both markets. As part of this agreement, Nasdaq and SGX -- who also share a successful, long-term market technology relationship -- are currently exploring the demand among corporates for a concurrent or sequential listing on both exchanges. Nasdaq and SGX are committed to supporting companies that are interested in pursuing this route. "The business landscape today is borderless," said Loh Boon Chye, CEO, SGX. "Fast-growing Asian companies looking to tap the capital markets can choose to list on SGX on Asian home ground, and embark on a listing on Nasdaq

Momentum Group acquires remaining 70 percent of Knut Sehlins Industrivaruhus in Örnsköldsvik18.10.2017 15:00Pressmeddelande

TOOLS Sweden (part of Momentum Group) has owned 30 percent of the shares in Knut Sehlins Industrivaruhus AB ("Sehlins") in Örnsköldsvik, Sweden since 2007. Today, TOOLS acquired the remaining 70 percent of the shares in Sehlins, which thus becomes a wholly owned subsidiary. Sehlins generates annual revenue of approximately MSEK 40 and has 14 employees. Sehlins is one of the leading industrial resellers in Örnsköldsvik, an attractive and important market with a number of successful industrial companies. The aim of the acquisition for TOOLS is to continue developing Sehlins as a wholly owned business with a focus on delivering optimal service for existing and potential customers in the local market. Sehlins has been part of TOOLS since the chain was formed in 2003. Closing takes place in October 2017. The acquisition is expected to have a marginal impact on Momentum Group's earnings per share during the current financial year. Stockholm, 18 October 2017

Momentum Group förvärvar resterande 70 procent av Knut Sehlins Industrivaruhus i Örnsköldsvik18.10.2017 15:00Pressmeddelande

TOOLS Sverige (inom Momentum Group-koncernen) är sedan 2007 delägare med 30 procent av aktierna i Knut Sehlins Industrivaruhus AB ("Sehlins") i Örnsköldsvik. TOOLS har idag förvärvat resterande 70 procent av aktierna i Sehlins, vilket härigenom blir ett helägt dotterbolag. Sehlins omsätter cirka 40 MSEK per år och har 14 anställda. Sehlins är en av de ledande industriåterförsäljarna i Örnsköldsvik, en intressant och viktig marknad med ett antal framgångsrika industriföretag. Syftet med TOOLS förvärv är att fortsätta utveckla Sehlins som en helägd verksamhet med fokus på att serva nuvarande och potentiella kunder på den lokala marknaden på bästa sätt. Sehlins har varit en del av TOOLS sedan starten av kedjan 2003. Tillträde sker i oktober 2017. Förvärvet bedöms ha en marginell påverkan på Momentum Groups resultat per aktie under innevarande räkenskapsår. Stockholm den 18 oktober 2017 Momentum Group AB (publ) För ytterligare inf

Colliers International Expands in Washington, D.C.18.10.2017 14:30Pressmeddelande

Acquisition of Beltway Real Estate Services Firm Strengthens Ongoing Commitment to the Region TORONTO and WASHINGTON, Oct.  18, 2017  (GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI)(TSX:CIGI) announced today the acquisition of leading tenant representation advisory firm Serten Advisors. With its office in Tysons Corner, the firm serves global, national, and regional clients with a highly skilled and experienced team of professionals that have more than 100 years of combined experience. "This strategic acquisition positions Colliers to gain additional market share and win new business in the vibrant and competitive Suburban DC markets," said Marty Pupil, Colliers International President | U.S. Brokerage. "Adding Steve and Paul and the rest of their talented leadership team to our existing group of professionals in the region will further position Colliers as the commercial real estate services firm of

InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC18.10.2017 14:00Pressmeddelande

InSphero AG / InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. New 3D InSight(TM) Human Liver Fibrosis Model represents a powerful tool for screening efficacy and safety of anti-fibrotic drugs in vitro. Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data characterizing and demonstrating the utility of its new 3D InSight(TM) Human Liver Fibrosis Model for screening efficacy of anti-fibrotic drugs.  The findings will be presented at oral and poster presentations this Friday at the annual meeting of the American Association for the Study of Liver Disease (AASLD) Conference in Washington, DC.  Anti-fibrotic therapi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum